Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Enzene Biosciences

Request full access

We are driven by the vision to positively impact the global healthcare landscape by delivering reliable and affordable medicines to improve life quality

Pune, IndiaFounded 2006Biotech & Life Sciences

About Enzene Biosciences

Enzene is a biotech startup based in India, specializing in the development of clinical and biosimilar products. The company has a robust pipeline of products that are on the brink of being launched in both the Indian and global markets. Enzene's business model revolves around B2B licensing opportunities, offering its innovative products to other businesses in the region.

The company is driven by a team of world-class scientists who are dedicated to making a significant impact on human lives. Their leadership team is highly experienced, with decades of experience in the pharmaceutical industry and recognition from industry bodies such as the Indian Drug Association.

Enzene operates in the biotech and pharmaceutical market, serving clients in the healthcare sector. They generate revenue through the sales of their products, with 32% of their revenue coming from offshore sales.

The company is also committed to maintaining high standards of environmental, health, and safety (EHS) performance. They regularly conduct inspections, audits, and reviews to ensure compliance with regulatory and company standards. They also invest in training and communication to raise awareness and develop knowledge about EHS issues.

Enzene is a subsidiary of Alkem, one of the top ten pharmaceutical companies in India. Alkem has a strong portfolio of over 800 brands and more than 1,300 SKUs across a wide range of therapy segments.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
993
Open positions
22
Dealroom signal
49.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Dec 2025 $33M — Alkem Laboratories ↗
LATE VCOther financing Jan 2023 $50M $200M Alkem Laboratories · Eight Roads Ventures · F-Prime ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Enzene Biosciences website traffic

Latest recorded traffic for Enzene Biosciences is 23K monthly website visits, up 109.1% over the last three months. Enzene Biosciences's team grew 6.3% over the past year.

Latest monthly visits23K 3-month web change+109.1% 1-year team growth+6.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Enzene Biosciences in the Pune ecosystem

Live from Dealroom

The Enzene Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later3 investors entered at this stage

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇮🇳 India67.9%
🇺🇸 United States5.7%
🇩🇪 Germany0.1%
🇨🇭 Switzerland0.1%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Enzene Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Enzene Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.